GlobeNewswire Clinical StudiesOriginal article
NTHU Becomes First in Taiwan to Successfully Treat Breast Cancer with BNCT, Achieving Significant Tumor Reduction
Data ReadoutpositiveBNCTPositive
AI Analysis
Summary
NTHU became the first institution in Taiwan to successfully treat recurrent triple-negative breast cancer using boron neutron capture therapy (BNCT), achieving significant tumor reduction in all five patients treated.
Clinical Trial Data
Primary Endpoint
Met
Patients
5
Outcome Details
Significant tumor reduction achieved in all five patients treated with BNCT for recurrent triple-negative breast cancer
Importance:5/10
Sentiment:
0.70
breast cancertriple-negativeBNCTTaiwanclinical dataoncology
Related Companies
Read the original article
Published by GlobeNewswire Clinical Studies on September 28, 2026 3:00 PM